Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A review of current and emerging therapeutic strategies in multiple sclerosis.
Childhood transverse myelitis and its mimics.
Characterization of Oligodendroglial Populations in Mouse Demyelinating Disease Using Flow Cytometry: Clues for MS Pathogenesis.
Changes in tissue directionality reflect differences in myelin content after demyelination in mice spinal cords.
[Retinal vasculitis as manifestation of multiple sclerosis.]
One step forward in the quest for evidence of the efficacy of cognitive rehabilitation in multiple sclerosis.
Vestibular-evoked myogenic potentials, clinical evaluation, and imaging findings in multiple sclerosis.
Notch Signaling and T-Helper Cells in EAE/MS.
Management of faecal incontinence and constipation in adults with central neurological diseases.
Water Extract from the Leaves of Withania somnifera Protect RA Differentiated C6 and IMR-32 Cells against Glutamate-Induced Excitotoxicity.
Obesity in autoimmune diseases: Not a passive bystander.
New hope for multiple sclerosis patients.
Structural and Dynamical Insights on HLA-DR2 Complexes That Confer Susceptibility to Multiple Sclerosis in Sardinia: A Molecular Dynamics Simulation Study.
Amyloid fibril formation and chaperone-like activity of peptides from alphaA-crystallin.
Hughes syndrome and Multiple sclerosis.
Small and Long Regulatory RNAs in the Immune System and Immune Diseases.
Examining Trait Mindfulness, Emotion Dysregulation, and Quality of Life in Multiple Sclerosis.
Who receives rehabilitation in canadian long-term care facilities? A cross-sectional study.
New Data Show Longer Tysabri Dosing Interval in MS Is Feasible
Circadian rhythm sleep disorders in patients with multiple sclerosis and its association with fatigue: A case-control study.
Responsiveness and Clinically Meaningful Improvement, According to Disability Level, of Five Walking Measures After Rehabilitation in Multiple Sclerosis: A European Multicenter Study.
Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.
Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis.
The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix.
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
310
311
312
313
314
315
316
317
318
…
next ›
last »